Screener
Axsome Therapeutics AXSM PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Inventories, net | 31,515 | 27,938 |
| Prepaid and other current assets | 23,523 | 13,651 |
| Total current assets | 611,206 | 588,986 |
| Equipment, net | 567 | 562 |
| Right-of-use asset - operating lease | 20,014 | 20,858 |
| Goodwill | 12,042 | 12,042 |
| Intangible asset, net | 38,947 | 40,519 |
| Non-current inventory and other assets | 30,831 | 26,838 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Axsome Therapeutics's PP&E (net)?
- Axsome Therapeutics (AXSM) reported PP&E (net) of $567K in Q1 2026.
- How has Axsome Therapeutics's PP&E (net) changed year-over-year?
- Axsome Therapeutics's PP&E (net) decreased by 26.6% year-over-year, from $773K to $567K.
- What is the long-term trend for Axsome Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Axsome Therapeutics's PP&E (net) has grown at a 60.6% compound annual growth rate (CAGR), from $52.65K to $562K.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Axsome Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude